Susquehanna International Group, LLP Bicycle Therapeutics PLC Put Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$19.58 - $27.24 $168,387 - $234,264	8,600 Added 86.87%	18,500 $419,000
Q2 2024 Aug 15, 2024	BUY	$20.02 - $24.69 $198,198 - $244,431	9,900 New	9,900 $200,000
Q4 2023 Feb 14, 2024	SELL	$13.29 - $22.2 $232,574 - $388,500	-17,500 Reduced 40.7%	25,500 $461,000
Q3 2023 Nov 14, 2023	BUY	$19.9 - $26.25 $244,769 - $322,875	12,300 Added 40.07%	43,000 $863,000
Q2 2023 Aug 11, 2023	SELL	$18.95 - $28.67 $119,385 - $180,621	-6,300 Reduced 17.03%	30,700 $783,000
Q1 2023 May 16, 2023	BUY	$20.02 - $31.37 $12,012 - $18,822	600 Added 1.65%	37,000 $786,000
Q4 2022 Feb 14, 2023	BUY	$20.37 - $32.9 $741,468 - $1.2 Million	36,400 New	36,400 $1.08 Million

113

40.8M

39.6K

24.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $390M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.